Immunocore Holdings (IMCR) Earnings Date & Reports
Immunocore Holdings PLC is a commercial-stage biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IMCR is expected to report earnings to fall 96.08% to 0 cents per share on August 06
Q2'26
Est.
$0.01
Q1'26
Beat
by $0.52
Q4'25
Missed
by $0.40
Q3'25
Beat
by $0.24
Q2'25
Missed
by $0.02
The last earnings report on May 07 showed earnings per share of 25 cents, beating the estimate of -27 cents. With 627.15K shares outstanding, the current market capitalization sits at 1.65B.